BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models
about
Chemical probes targeting epigenetic proteins: Applications beyond oncology.Combinatorial Screening of Pancreatic Adenocarcinoma Reveals Sensitivity to Drug Combinations Including Bromodomain Inhibitor Plus Neddylation Inhibitor.The cancer epigenome: Concepts, challenges, and therapeutic opportunities.BET Proteins: An Approach to Future Therapies in Transplantation.CAR T-cell therapy of solid tumors.BET Bromodomain Proteins as Cancer Therapeutic Targets.Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy.Curtailed T-cell activation curbs effector differentiation and generates CD8+ T cells with a naturally-occurring memory stem cell phenotype.Therapeutic T cell engineering.Transient stimulation expands superior antitumor T cells for adoptive therapy.BETting on combination to overcome PARPi resistance.Chromatin dependencies in cancer and inflammation.PI3K orchestration of the in vivo persistence of chimeric antigen receptor-modified T cells.Immunotherapy With Human Gamma Delta T Cells-Synergistic Potential of Epigenetic Drugs?DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models.Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors
P2860
Q33751386-F5789345-A7CD-4193-A089-2C10287934B1Q38712272-5AA20C89-C746-4517-936C-DAF22C2C71BEQ38743881-4E7A87D0-A197-49C1-B780-B6552E0F8981Q38760291-7B1AA06B-EE09-4E8E-BF3D-2EA012329449Q39047856-1B771C99-EAD0-4615-A508-07BBB90866D4Q39071349-129D960B-EC3D-4DB3-86A3-EF66A00727F4Q39418546-24896790-F7CA-4FA4-966A-486ACAB42343Q40149591-C1A369F7-02AB-428D-BE79-F633807D823AQ40199809-FDB860AF-BBCB-4982-B2CF-610B2B6DE176Q42328616-34C35D4E-9CD9-47B2-B3F6-8C2B1655E522Q47093793-7F23B87A-0BFA-4D92-AB16-2D032F9AC54BQ49565575-B4044138-FD0F-496F-A249-905D5D312458Q50534706-D5D9E6C9-50D3-4CB3-B4F0-2F22B29150CBQ55030400-4E0F5FC9-CC04-43B7-ABA8-0EB601A3B0C7Q55322590-0C242963-B2F7-4C85-9938-52EDC82FC5FEQ56892267-3F1F6A32-6126-4088-9A34-C8BC8D730DAB
P2860
BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
BET bromodomain inhibition enh ...... adoptive immunotherapy models
@ast
BET bromodomain inhibition enh ...... adoptive immunotherapy models
@en
type
label
BET bromodomain inhibition enh ...... adoptive immunotherapy models
@ast
BET bromodomain inhibition enh ...... adoptive immunotherapy models
@en
prefLabel
BET bromodomain inhibition enh ...... adoptive immunotherapy models
@ast
BET bromodomain inhibition enh ...... adoptive immunotherapy models
@en
P2093
P2860
P356
P1476
BET bromodomain inhibition enh ...... adoptive immunotherapy models
@en
P2093
Kayoko Saso
Mark Anczurowski
Munehide Nakatsugawa
Naoto Hirano
Tingxi Guo
Toshiki Ochi
Yuki Kagoya
Yuki Yamashita
P2860
P304
P356
10.1172/JCI86437
P407
P577
2016-09-01T00:00:00Z